Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges

Autores
Piñero, Federico; Poniachik, Jaime; Ridruejo, Ezequiel; Silva, Marcelo
Año de publicación
2018
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Latin America, a region with a population greater than 600000000 individuals, is well known due to its wide geographic, socio-cultural and economic heterogeneity. Access to health care remains as the main barrier that challenges routine screening, early diagnosis and proper treatment of hepatocellular carcinoma (HCC). Therefore, identification of population at risk, implementation of surveillance programs and access to curative treatments has been poorly obtained in the region. Different retrospective cohort studies from the region have shown flaws in the implementation process of routine surveillance and early HCC diagnosis. Furthermore, adherence to clinical practice guidelines recommendations assessed in two studies from Brazil and Argentina demonstrated that there is also room for improvement in this field, similarly than the one observed in Europe and the United States. In summary, Latin America shares difficulties in HCC decision-making processes similar to those from developed countries. However, a transversal limitation in the region is the poor access to health care with the consequent limitation to standard treatments for overall population. Specifically, universal health care access to the different World Health Organization levels is crucial, including improvement in research, education and continuous medical training in order to expand knowledge and generation of data promoting a continuous improvement in the care of HCC patients.
Fil: Piñero, Federico. Educational And Awareness Network; Argentina. Hospital Universitario Austral; Argentina
Fil: Poniachik, Jaime. Hospital Clinico de la Universidad de Chile; Chile. Clinica Santa Maria; Chile
Fil: Ridruejo, Ezequiel. Hospital Universitario Austral; Argentina. Educational And Awareness Network; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina
Fil: Silva, Marcelo. Hospital Universitario Austral; Argentina. Educational And Awareness Network; Argentina
Materia
CHALLENGE
LATIN AMERICA
LIMITATIONS
LIVER CANCER
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/86462
Acceder
id CONICETDig_5aac8b228ab06716c54d122b48a3f67d
oai_identifier_str oai:ri.conicet.gov.ar:11336/86462
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Hepatocellular carcinoma in Latin America: Diagnosis and treatment challengesPiñero, FedericoPoniachik, JaimeRidruejo, EzequielSilva, MarceloCHALLENGELATIN AMERICALIMITATIONSLIVER CANCERhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Latin America, a region with a population greater than 600000000 individuals, is well known due to its wide geographic, socio-cultural and economic heterogeneity. Access to health care remains as the main barrier that challenges routine screening, early diagnosis and proper treatment of hepatocellular carcinoma (HCC). Therefore, identification of population at risk, implementation of surveillance programs and access to curative treatments has been poorly obtained in the region. Different retrospective cohort studies from the region have shown flaws in the implementation process of routine surveillance and early HCC diagnosis. Furthermore, adherence to clinical practice guidelines recommendations assessed in two studies from Brazil and Argentina demonstrated that there is also room for improvement in this field, similarly than the one observed in Europe and the United States. In summary, Latin America shares difficulties in HCC decision-making processes similar to those from developed countries. However, a transversal limitation in the region is the poor access to health care with the consequent limitation to standard treatments for overall population. Specifically, universal health care access to the different World Health Organization levels is crucial, including improvement in research, education and continuous medical training in order to expand knowledge and generation of data promoting a continuous improvement in the care of HCC patients.Fil: Piñero, Federico. Educational And Awareness Network; Argentina. Hospital Universitario Austral; ArgentinaFil: Poniachik, Jaime. Hospital Clinico de la Universidad de Chile; Chile. Clinica Santa Maria; ChileFil: Ridruejo, Ezequiel. Hospital Universitario Austral; Argentina. Educational And Awareness Network; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; ArgentinaFil: Silva, Marcelo. Hospital Universitario Austral; Argentina. Educational And Awareness Network; ArgentinaW J G Press2018-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/86462Piñero, Federico; Poniachik, Jaime; Ridruejo, Ezequiel; Silva, Marcelo; Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges; W J G Press; World Journal of Gastroenterology; 24; 37; 10-2018; 4224-42291007-93272219-2840CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3748/wjg.v24.i37.4224info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T11:02:15Zoai:ri.conicet.gov.ar:11336/86462instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 11:02:15.381CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
title Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
spellingShingle Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
Piñero, Federico
CHALLENGE
LATIN AMERICA
LIMITATIONS
LIVER CANCER
title_short Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
title_full Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
title_fullStr Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
title_full_unstemmed Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
title_sort Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
dc.creator.none.fl_str_mv Piñero, Federico
Poniachik, Jaime
Ridruejo, Ezequiel
Silva, Marcelo
author Piñero, Federico
author_facet Piñero, Federico
Poniachik, Jaime
Ridruejo, Ezequiel
Silva, Marcelo
author_role author
author2 Poniachik, Jaime
Ridruejo, Ezequiel
Silva, Marcelo
author2_role author
author
author
dc.subject.none.fl_str_mv CHALLENGE
LATIN AMERICA
LIMITATIONS
LIVER CANCER
topic CHALLENGE
LATIN AMERICA
LIMITATIONS
LIVER CANCER
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Latin America, a region with a population greater than 600000000 individuals, is well known due to its wide geographic, socio-cultural and economic heterogeneity. Access to health care remains as the main barrier that challenges routine screening, early diagnosis and proper treatment of hepatocellular carcinoma (HCC). Therefore, identification of population at risk, implementation of surveillance programs and access to curative treatments has been poorly obtained in the region. Different retrospective cohort studies from the region have shown flaws in the implementation process of routine surveillance and early HCC diagnosis. Furthermore, adherence to clinical practice guidelines recommendations assessed in two studies from Brazil and Argentina demonstrated that there is also room for improvement in this field, similarly than the one observed in Europe and the United States. In summary, Latin America shares difficulties in HCC decision-making processes similar to those from developed countries. However, a transversal limitation in the region is the poor access to health care with the consequent limitation to standard treatments for overall population. Specifically, universal health care access to the different World Health Organization levels is crucial, including improvement in research, education and continuous medical training in order to expand knowledge and generation of data promoting a continuous improvement in the care of HCC patients.
Fil: Piñero, Federico. Educational And Awareness Network; Argentina. Hospital Universitario Austral; Argentina
Fil: Poniachik, Jaime. Hospital Clinico de la Universidad de Chile; Chile. Clinica Santa Maria; Chile
Fil: Ridruejo, Ezequiel. Hospital Universitario Austral; Argentina. Educational And Awareness Network; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina
Fil: Silva, Marcelo. Hospital Universitario Austral; Argentina. Educational And Awareness Network; Argentina
description Latin America, a region with a population greater than 600000000 individuals, is well known due to its wide geographic, socio-cultural and economic heterogeneity. Access to health care remains as the main barrier that challenges routine screening, early diagnosis and proper treatment of hepatocellular carcinoma (HCC). Therefore, identification of population at risk, implementation of surveillance programs and access to curative treatments has been poorly obtained in the region. Different retrospective cohort studies from the region have shown flaws in the implementation process of routine surveillance and early HCC diagnosis. Furthermore, adherence to clinical practice guidelines recommendations assessed in two studies from Brazil and Argentina demonstrated that there is also room for improvement in this field, similarly than the one observed in Europe and the United States. In summary, Latin America shares difficulties in HCC decision-making processes similar to those from developed countries. However, a transversal limitation in the region is the poor access to health care with the consequent limitation to standard treatments for overall population. Specifically, universal health care access to the different World Health Organization levels is crucial, including improvement in research, education and continuous medical training in order to expand knowledge and generation of data promoting a continuous improvement in the care of HCC patients.
publishDate 2018
dc.date.none.fl_str_mv 2018-10
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/86462
Piñero, Federico; Poniachik, Jaime; Ridruejo, Ezequiel; Silva, Marcelo; Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges; W J G Press; World Journal of Gastroenterology; 24; 37; 10-2018; 4224-4229
1007-9327
2219-2840
CONICET Digital
CONICET
url http://hdl.handle.net/11336/86462
identifier_str_mv Piñero, Federico; Poniachik, Jaime; Ridruejo, Ezequiel; Silva, Marcelo; Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges; W J G Press; World Journal of Gastroenterology; 24; 37; 10-2018; 4224-4229
1007-9327
2219-2840
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.3748/wjg.v24.i37.4224
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv W J G Press
publisher.none.fl_str_mv W J G Press
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846781226058252288
score 12.982451

Publicaciones similares